Skip to Main Content

Paper Details

Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City.
Neurol Clin Pract
3
2022
Author NameAffiliation
Soojin ParkColumbia University Irving Medical Center-New York Presbyterian Hospital United States Centers for Disease Control and Prevention (VTC, Columbia University Irving Medical Center-New York Presbyterian Hospital and Division of Infectious Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital (MES
Wendy G SilverColumbia University Irving Medical Center-New York Presbyterian Hospital United States Centers for Disease Control and Prevention (VTC, Columbia University Irving Medical Center-New York Presbyterian Hospital and Division of Infectious Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital (MES
Andrew S GeneslawColumbia University Irving Medical Center-New York Presbyterian Hospital United States Centers for Disease Control and Prevention (VTC, Columbia University Irving Medical Center-New York Presbyterian Hospital and Division of Infectious Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital (MES
Jan ClaassenColumbia University Irving Medical Center-New York Presbyterian Hospital United States Centers for Disease Control and Prevention (VTC, Columbia University Irving Medical Center-New York Presbyterian Hospital and Division of Infectious Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital (MES
Mitchell S V ElkindColumbia University Irving Medical Center-New York Presbyterian Hospital United States Centers for Disease Control and Prevention (VTC, Columbia University Irving Medical Center-New York Presbyterian Hospital and Division of Infectious Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital (MES
  • 1 - 5

Datasets